Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Therapeutic Contact Lenses Market to Grow Significantly

A recent report by Future Market Insights has made some exciting predictions about the therapeutic contact lenses market. The report states that the market is set to experience significant growth in the next decade, rising from an estimated USD 12,595.3…

Natural Compound as Effective Contact Lens Disinfectant

A recent study suggests that a naturally-occurring material could serve as an effective disinfectant for contact lenses, providing potentially groundbreaking implications for millions of wearers worldwide. Microbial keratitis, a severe complication for contact lens users, is caused by bacterial infections,…

Llama-Derived Antibody May Treat Retinitis Pigmentosa

A group of researchers from the University of California, Irvine, has made a significant discovery: an exceptional antibody that could pave the way for treating Retinitis Pigmentosa. This condition results in the deterioration of central vision, as well as night…

Micro Labs Launches World’s First Triple-Drug for Glaucoma

Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…

Toxic Truth: Chemicals in Contact Lenses Linked to Cancer

*This news has been updated.  A marker of certain chemicals that might cause cancer, liver disease, and autoimmune diseases, organic fluorine was detected in unusually high quantities in lab tests on 18 popular types of contact lenses. Health Risks Associated…

Global Pharma Healthcare Recalls EzriCare Eye Drops

Global Pharma Healthcare is recalling its Artificial Tears Lubricant Eye Drops due to potential contamination. The recall affects all lots within expiry and covers products distributed by EzriCare LLC and Delsam Pharma. This comes after the CDC informed the FDA…

FDA Warns of Delsam Pharma’s Artificial Eye Ointment

The FDA has issued a warning to consumers and healthcare professionals not to purchase or use Delsam Pharma’s Artificial Eye Ointment due to potential bacterial contamination. This eye oinment is an over-the-counter product, intended to be sterile and produced by…

Stay informed and not overwhelmed, subscribe now!